Search Results - "UMPIERREZ, G. E"

Refine Results
  1. 1

    Relationship between weight change and glycaemic control in patients with type 2 diabetes receiving once-weekly dulaglutide treatment by Umpierrez, G. E., Pantalone, K. M., Kwan, A. Y. M., Zimmermann, A. G., Zhang, N., Fernández Landó, L.

    Published in Diabetes, obesity & metabolism (01-06-2016)
    “…Aim To assess the relationship between weight change and glycated haemoglobin (HbA1c) change in dulaglutide‐treated patients by analysing data from six…”
    Get full text
    Journal Article
  2. 2

    Evaluation of a comprehensive diabetic foot ulcer care quality model by Schechter, M.C., Fayfman, M., Khan, L.S.M.F., Carr, K., Patterson, S., Ziemer, D.C., Umpierrez, G.E., Rajani, R., Kempker, R.R.

    Published in Journal of diabetes and its complications (01-04-2020)
    “…Diabetes-related amputations are typically preceded by a diabetic foot ulcer (DFU) but models to assess the quality of care are lacking. We investigated a…”
    Get full text
    Journal Article
  3. 3

    The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome by Thoenes, M, Oguchi, A, Nagamia, S, Vaccari, C S, Hammoud, R, Umpierrez, G E, Khan, B V

    “…Niacin is an agent that significantly increases high-density lipoprotein cholesterol (HDL-C), but its effects on surrogate markers of atherosclerosis and…”
    Get more information
    Journal Article
  4. 4

    Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress by Merchant, N, Rahman, S T, Ferdinand, K C, Haque, T, Umpierrez, G E, Khan, B V

    Published in Journal of human hypertension (01-03-2011)
    “…We sought to determine whether the antihypertensive drug nebivolol has beneficial effects on vascular markers of inflammation and oxidation in obese…”
    Get full text
    Journal Article
  5. 5

    Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects by Velasquez-Mieyer, P.A, Cowan, P.A, Umpierrez, G.E, Lustig, R.H, Cashion, A.K, Burghen, G.A

    Published in International Journal of Obesity (01-11-2003)
    “…Obese African-American (AA) subjects have higher resting and stimulated insulin concentrations than obese Caucasians (C), which could not be explained by the…”
    Get full text
    Journal Article
  6. 6

    Diabetic ketoacidosis in obese African-Americans by Umpierrez, G. E., Casals, M. M., Gebhart, S. P., Mixon, P. S., Clark, W. S., Phillips, L. S.

    Published in Diabetes (New York, N.Y.) (01-07-1995)
    “…Diabetic ketoacidosis in obese African-Americans. G E Umpierrez , M M Casals , S P Gebhart , P S Mixon , W S Clark and L S Phillips Department of Medicine,…”
    Get full text
    Journal Article
  7. 7

    The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes by Idrees, T., Zabala, Z.E., Moreno, E.M., Gerges, A., Urrutia, M.A., Ruiz, J.G., Vaughan, C., Vellanki, P., Pasquel, F.J., Peng, L., Umpierrez, G.E.

    Published in Diabetes research and clinical practice (01-04-2023)
    “…Older adults with diabetes in the hospital are generally managed similarly to younger adults, however, it is unknown if the degree of frailty can affect…”
    Get full text
    Journal Article
  8. 8

    Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis by UMPIERREZ, G. E, WOO, W, HAGOPIAN, W. A, ISAACS, S. D, PALMER, J. P, GAUR, L. K, NEPOM, G. T, CLARK, W. S, MIXON, P. S, KITABCHI, A. E

    Published in Diabetes care (01-09-1999)
    “…Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. G E Umpierrez , W Woo , W A Hagopian ,…”
    Get full text
    Journal Article
  9. 9

    The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study by Umpierrez, G. E., Blevins, T., Rosenstock, J., Cheng, C., Anderson, J. H., Bastyr III, E. J.

    Published in Diabetes, obesity & metabolism (01-05-2011)
    “…Aim: To evaluate the efficacy and tolerability of once‐weekly LY2189265 (LY), a novel glucagon‐like peptide‐1 (GLP‐1) IgG4‐Fc fusion protein, in patients with…”
    Get full text
    Journal Article
  10. 10

    Incidence and care-related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project by Barranco, R. J., Gomez-Peralta, F., Abreu, C., Delgado, M., Palomares, R., Romero, F., Morales, C., de la Cal, M. A., Garcia-Almeida, J. M., Pasquel, F., Umpierrez, G. E.

    Published in Diabetic medicine (01-11-2015)
    “…Aims Hypoglycaemia is a serious medical emergency. The need for emergency medical service care and the costs of hypoglycaemic emergencies are not completely…”
    Get full text
    Journal Article
  11. 11

    Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults by VELASQUEZ-MIEYER, P. A, UMPIERREZ, G. E, LUSTIG, R. H, CASHION, A. K, COWAN, P. A, CHRISTENSEN, M, SPENCER, K. A, BURGHEN, G. A

    Published in International Journal of Obesity (01-02-2004)
    “…This study investigated (1) the effect of octreotide-LAR (Sandostatin-LAR Depot; Novartis) on the enteroinsular axis in a biracial cohort of severely obese…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Incidence, recurrence and cost of hyperglycaemic crises requiring emergency treatment in Andalusia, Spain by Barranco, R. J., Gomez‐Peralta, F., Abreu, C., Delgado‐Rodriguez, M., Moreno‐Carazo, A., Romero, F., de la Cal, M. A., Barranco, J. M., Pasquel, F. J., Umpierrez, G. E.

    Published in Diabetic medicine (01-07-2017)
    “…Aims Hyperglycaemic crises (diabetic ketoacidosis and hyperosmolar hyperglycaemic state) are medical emergencies in people with diabetes. We aimed to determine…”
    Get full text
    Journal Article
  13. 13

    Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises by UMPIERREZ, G. E, CLARK, W. S, STEEN, M. T

    Published in Diabetes care (01-04-1997)
    “…Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. G E Umpierrez , W S…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Diabetic muscle infarction by Umpierrez, G E, Stiles, R G, Kleinbart, J, Krendel, D A, Watts, N B

    Published in The American journal of medicine (01-09-1996)
    “…To describe the clinical, histologic, and radiologic findings in patients with diabetic muscular infarction (DMI). Descriptive case series of 3 patients with…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Decreased collagen production in diabetic rats by Spanheimer, R. G., Umpierrez, G. E., Stumpf, V.

    Published in Diabetes (New York, N.Y.) (01-04-1988)
    “…Decreased collagen production in diabetic rats. R G Spanheimer , G E Umpierrez and V Stumpf Department of Medicine, Emory University School of Medicine,…”
    Get full text
    Journal Article
  19. 19

    Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism by Umpierrez, G E, Challapalli, S, Patterson, C

    “…The authors describe the clinical characteristics and response to therapy of seven patients with hyperthyroidism, dilated cardiomyopathy, and low-output…”
    Get more information
    Journal Article
  20. 20